The QualityStocks Daily Newsletter for Tuesday September 29th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Greenbackers (ASTC)


OTC Picks (CBAI)


Shazamstocks.com (GSAE)

The QualityStocks Daily

The Tradeshow Marketing Company, Ltd. (TSHO)

Emerging Stock Report reported yesterday on The Tradeshow Marketing Company, Ltd. (TSHO), and today we highlight the Company as "One to Watch", here at the QualityStocks Daily Newsletter.

Established in 2003, The TradeShow Marketing Company, Ltd. is a consumer products company. Their focus is on the development and distribution of unique products that have broad appeal and improve the lives of consumers. The Company operates a direct demonstration business via trade shows and exhibitions throughout North America. They also have various product-specific e-commerce web sites.

Recently, Tradeshow Marketing Company, Ltd. announced that they are working towards upgrading their Pink Sheets Electronic OTC Markets disclosure status to Current Information, with a target date for completing this process of September 30, 2009. By upgrading their status to Current Information, the Company will be joining the ranks of Pink Sheets companies that contribute to 88 percent of the average dollar volume when compared with the two lower Pink Sheets tiers.

Earlier this month, Tradeshow Marketing Company, Ltd. announced that they launched their exclusive Risoli™ Titanium Induction cookware set. The Company chose a titanium induction combination for their set because of the advantages it has over most conventional cookware. The set is lightweight and durable because of the Titanium and fused Aluminum construction. In addition, cooking is faster, safer, and more energy efficient when used with an induction cooker.

Yesterday, The Tradeshow Marketing Company, Ltd. announced that they completed an agreement with Seattle-based Cesari Direct. This agreement is for the production of an upcoming short-form Direct Response Television campaign, anticipated to debut on National Television later next month.

"Cesari Direct is a highly reputable company in the DRTV media production field", said Luniel de Beer, CEO of Tradeshow Marketing. He continued that, "Their experience and success, along with their commitment to excellence, made them our first choice as a partner, and I am very pleased that we were able to complete this agreement with them."

We're tracking The Tradeshow Marketing Company, Ltd. (TSHO) as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

The Tradeshow Marketing Company, Ltd. (TSHO) closed Tuesday's trading session at $0.45 down 18.18 percent. Volume was 415,742.


Emergent Health Corp. (EMGE)

Topgun stockpicks reported yesterday on Emergent Health Corp. (EMGE). Momentum Traders, ‏BestDamnPennyStocks, PennyStockPerfection.com, Monster Penny Stocks, Profit Growth Report, The Capital Report, Monster Stock Alerts, MicrocapVoice, Momentum Trades, Wise Alerts, PennyOmega.com, MonsterStocksPicks did last week, and today we highlight the Company as "One to Watch", here at the QualityStocks Daily Newsletter.

Emergent Health Corp. is a multi-specialty biotechnology organization. Their focus is on the discovery, development, innovation, and commercialization of formulas, adjuvants, and non-prescription products for mass markets. Trading on the Pink Sheets, the Company focuses on the health and wellness industry. They have a developing product line in the field of regenerative medicine, and enhanced neutraceuticals and phytonutritionals without a prescription. Emergent Health Corp. has their headquarters in King of Prussia, Pennsylvania.

Emergent Health Corp. markets their products through health food stores and dispensing physicians. Their principal product pipeline includes Vita-Stim to enhance the immune system, nourish stem cells, and maintain optimal health. They also have their Neuvitale to increase adult stem cells and act as a methyl donor to protect DNA, and add to quality and quantity of life. They also have their Hungarest to help lose weight by stopping appetite naturally in the brain and stomach simultaneously. In addition, the Company has a Wrinkle Reduction product to decrease facial wrinkles without the need for painful injections. The Company also has other products that are under review.

The Company's Research and Development projects include a product for Erectile Dysfunction known in-house as ERDEX. They also are working on a product for Peyronies Disease known in-house as PX. The Company is also working on a product designed to enhance hair growth known in-house as Hair-Gain. In addition, they have a project concerning a product designed to regenerate new and younger skin with stem cells, known in-house as YoungSkin.

For Product Launches, Emergent Health Corp. considers licensing of patented and patent pending products through companies with known distribution. They also consider private labeling of patented and patent pending products through other channels of distribution. Additionally, they consider direct launching of their products through a company-designed method of distribution.

Last week, Emergent Health Corp. announced that they plan to introduce an adjuvant formula that enhances existing vitamin products currently on the market. This is to assist in the production of normal cells. This product is Vita-Stim Adjuvant™. It is a trademarked and patented formula. With this product, existing vitamin companies will be able to deliver scientifically advanced vitamin products and formulas to United States and international customers.

We're keeping an eye on Emergent Health Corp. (EMGE), and tracking them on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter. ‏

Today, Emergent Health Corp. (EMGE) closed at $1.85 down 21.28 percent. Volume was 333,843 for a 3-month average of 87,244.

A123 Systems, Inc. (AONE)

Today, The Street reported on A123 Systems, Inc. (AONE), MarketWatch did yesterday, Momentum Traders and Greenbackers did last week, and we are highlighting the Company as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Headquartered in Watertown, Massachusetts, A123 Systems, Inc. designs, develops, manufactures, and sells advanced, rechargeable lithium-ion batteries and battery systems. They do this for the transportation, electric grid services, and consumer markets. Founded in 2001, A123 Systems built their proprietary nanoscale electrode technology on initial developments from the Massachusetts Institute of Technology.

A123 Systems, Inc. believes that lithium-ion batteries will play an increasingly important role in facilitating a shift toward cleaner forms of energy. They have developed a broad family of high-power lithium-ion batteries and battery systems using their innovative approach to materials science and battery engineering. Their low impedance Nanophosphate electrode technology provides performance advantages over alternative high power technologies.

Nanophosphate is a positive electrode material of excellent rate capability, critical to high power systems. A123 Systems, Inc.’s high power products are able to pulse at discharge rates up to 100C. They are of a low impedance and thermally conductive design. A123 high power cells can be continuously discharged at a 35C rate.

They designed their cell and electrodes to deliver low cost/watt and cost/watt-hour performance. They have higher voltage than other long-life systems, enabling lower pack cost (when compared to LTO and NiMh). In addition, their long life leads to reduced lifecycle and system costs.

The Company designed their Nanophosphate™ technology to be highly abuse tolerant. They have multiple layers of protection employed at the chemistry, cell, and pack level. This is to achieve an energy storage solution with superior safety and abuse tolerance compared to metal oxide lithium ion. A123 Systems projects their batteries to last up to 10 years. They are suitable for automotive applications including hybrid electric vehicles (HEV) and plug-in hybrid electric vehicles (PHEV).

We're tracking A123 Systems, Inc. (AONE) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

A123 Systems, Inc. (AONE) closed Tuesday's trading session at $19.80 up 5.71 percent. Volume was 4,211,478 for a 3-month average of 3,669,300.

Midex Gold Corp. (MXGD)

Simply Best Penny Stocks, Top Best Pennystocks, Monster Stock Alerts, Penny Stock Explosion, 24-7 Stock Alert, and Penny Invest all reported this month on Midex Gold Corp. (MXGD), and we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Midex Gold Corp. is working to take advantage of Tanzania's rich mineral resources. The Company is developing a select portfolio of near-term gold and diamond production projects. As an OTCBB-traded enterprise, they are poised to identify key mining concession targets that are ready for development. The Company has a network of strategic relationships with senior mining professionals and government officials in Tanzania.

Midex Gold Corp.'s major property is the Magembe Property.  The Magembe Property Project is a diamond exploration target, and is part of a two-kilometer buffer zone created to surround the Williamson Mine (aka Mwadui) when it underwent development in the 1940s and 50s. The formation of this buffer zone was to prohibit the mining of near-surface diamond deposits in the area immediately adjacent to the mining operation. In 2003 the Mining Act was reformed, and Midex Corp. acquired the property in 2009. Canadian geologist Dr. John Williamson discovered the mine in 1940. It is the largest economically exploitable pipe in the world.

The Company's management has identified several mineral exploration and development opportunities in East Africa, specifically Tanzania. They are working to develop opportunities in Tanzania. In 1998, the country instituted a new mining act that attracted numerous international mining companies. The country has vast amounts of undeveloped mineral-rich natural resources. It has one of the world's largest diamond producing mines and is the third largest gold producer in Africa.

There is the expectation that the mining industry in Tanzania will grow at an average of 11.92 percent through 2013. This is according to Business Monitor International forecasts. Two global mining companies are currently operating premier gold mines in Tanzania. AngloGold's Geita Mine with 18 million proven ounces and Barrick's Bulyanhulu Mine with 12 million ounces are highly productive mines. Their 2009 annual production is running at 250,000 and 200,000 ounces of gold respectively.

Midex Gold Corp.'s Magembe property consists of one claim covering 46.05 km², PL 3920. Its location is along the main highway between Shinyanga and Mwanza, approximately 35 kilometers NNW of Shinyanga town. The land is flat and moderately vegetated with slightly elevated ground in the northern part.

Earlier this month, Morgan Magella, president of Midex Gold talked about Russian mining company Petra Diamonds buying De Beers' 75 percent equity stake in the Williamson (Mwadui) Mine, one of Africa's top diamond producing mines. Mr. Magella stated that, "The sale of Africa's most prolific diamond producing mine to Petra Diamonds Limited further reinforces our belief that our 46 square kilometer Magembe diamond property that is directly adjacent to the eastern, northern, and western boundaries of the Williamson (Mwadui) Mine has the potential to become a world-class diamond mine."

Midex Gold Corp. (MXGD) closed today's trading session at $0.0660 up 1.54 percent. Volume was 561,860.

Maxygen Inc. (MAXY)

Tiny Gems reported this month on Maxygen Inc. (MAXY), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Maxygen Inc. focuses on the discovery, development, and marketing of protein pharmaceuticals for the treatment of disease and medical conditions. Their products are for the fight against cancer, hemostatis, and rheumatoid arthritis. Founded in 1997, the Company's headquarters are in Redwood City, California, and they trade on NASDAQ. Their focus is on developing a series of technologies designed to improve specific properties of genes and proteins to create effective therapies to treat disease. Maxygen Inc.  primarily uses their MolecularBreeding™ directed evolution technology platform, along with ancillary technologies, to create proprietary proteins.

Maxygen has different protein pharmaceutical programs. MAXY-G34 is a granulocyte colony-stimulating factor (G-CSF) protein to treat neutropenia.  "Neutropenia" is a condition of an abnormally low number of a type of white blood cell called a neutrophil. The Company's MAXY-4 is an improved CTLA4-Ig protein to treat rheumatoid arthritis as well as other immune or autoimmune diseases. They partnered with Astellas Pharma, Inc., under which the Company and Astellas are exploring new CTLA4-Ig product candidates for the treatment of rheumatoid arthritis, transplantation rejection, and other autoimmune disorders.

In 2008, Maxygen Inc. sold their hemophilia treatment program to Bayer's health care division for $90 million, in addition to $30 million in future milestone payments. Bayer acquired Maxygen's lead drug candidate MAXY-VII, along with a license to use their underlying gene targeting technology. MAXY-VII is an improved factor VIIa protein to treat hemophilia and acute bleeding conditions.

Earlier this year, Maxygen, Inc. announced that they entered into an agreement with Cangene Corporation. They granted Cangene an option to obtain an exclusive license to Maxygen’s proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome (ARS). Under the agreement, Cangene has paid Maxygen an up-front fee of $500,000. If Cangene receives a specified government development contract that meets certain Cangene criteria, Cangene would exercise an option for an initial license and pay Maxygen an initial licensing fee.

Maxygen would also be entitled to additional licensing fees based upon a percentage of Cangene's net contract revenues under the development contract. Maxygen Inc. retained all rights to MAXY-G34 for commercial development of all therapeutic areas outside of the ARS indication. This includes all rights for chemotherapy-induced neutropenia indications.

Last week, Maxygen, Inc. announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc.  Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly formed joint venture, Perseid Therapeutics LLC. This joint venture is to focus on the discovery, research, and development of multiple protein pharmaceutical programs.

Maxygen Inc. (MAXY) closed today at $6.85 up 0.15 percent. Volume today was 126,931 for a 3-month average volume of 176,336 shares.


XenaCare Holdings Inc. (XCHO)

We are highlighting XenaCare Holdings Inc. (XCHO), here at the QualityStocks Daily Newsletter.

XenaCare Holdings Inc. is a company specializing in the marketing and retail distribution of consumer healthcare products. Headquartered in Delray Beach, Florida, the Company markets their products through the Internet, pharmacies, and doctors offices. Founded in 2001, XenaCare Holdings Inc. trades on the OTCBB. The Company is part of the Biotechnology industry in the Healthcare sector.

XenaCare has launched the SunPill. This pill is a dietary supplement that helps the skin protect itself from the harmful rays of the sun. The SunPill is currently available at RiteAid, CVS.com, Drugstore.com, Amazon.com, and many other mass-market retailers. Additionally, in May of this year, XenaCare Holdings Inc. announced that they received the exclusive U.S. license to market and distribute an FDA-approved homeopathic treatment for chronic pain.

In June of this year, the Company reported that they received the exclusive license to market and distribute a cellular cleanse and detoxification product. The product is used as an effective solution for removing heavy metals and toxins from the body. Research has also shown that the product's ingredients may help reduce viral replication and support healthy blood sugar levels.

In addition, this product improves nutrient absorption, supports immune system function, and reduces symptoms of allergies. XenaCare's new product has the ability to detoxify the entire body, not just the digestive system. The Detoxification market is one of the fastest growing nutritional markets in the U.S. with current estimates at over $4 billion annually.

XenaCare is preparing to release a skin care product. This product goes by the name Pro Dermex for use in dermatologists' offices. It is for healthier skin and reduction of skin damage caused by the sun. The product will sell to the 16,000 practicing dermatologists in the U.S., with a focus on the 2,500 stocking dermatologists.

Recently, Nutra Pharma Corp. completed a licensing agreement that grants XenaCare Holdings the exclusive marketing and distribution rights to Cobroxin within the United States.

Cobroxin is the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The drug will be available in October as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuralgia. It will also be available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

Today, XenaCare Holdings Inc. (XCHO) closed trading at $0.14 up 60.71 percent. Volume was 1,654,517 shares for a 3-month average of 464,314.

Wentworth Energy, Inc. (WNWG)

Today we are highlighting Wentworth Energy, Inc. (WNWG), here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Wentworth Energy, Inc. is an independent exploration and production company focused on developing North American oil and natural gas reserves. The Company currently has oil and gas interests in Anderson County, Freestone County, and Jones County, Texas. Wentworth Energy, Inc. has their corporate headquarters in Palestine, Texas.

Wentworth Energy applies innovative technologies toward the discovery and development of a diverse portfolio of high-value, low-risk energy projects in North America. The Company's East Texas mineral block is on trend with the three active areas of East Texas, the Bossier Sand, Cotton Valley Lime, and the Cotton Valley Pinnacle Reef Trend. Activity within these trends has been high for several years and the projection is that this will continue.

Wentworth Energy, Inc.'s current production comes from two wells, Shiloh #1 and #3 in Freestone County. Shiloh #3 underwent recompletion from the Cotton Valley zone to the Rodessa zone during June 2008. Most of the production comes from Shiloh #3 with an average daily gross production of 800 MCF of gas. The Company owns a 38.75 percent and 38.5 percent net revenue interest in Shiloh #1 and #3, respectively, and was the operator of these wells until June 30, 2009. Effective July 1, 2009, the operation of the working interest wells, including the Shiloh #1 and #3, was transferred to a local East Texas oil and gas company.

Early in July of this year, Wentworth Energy, Inc. announced that they entered into a six-month lease extension with their current Lessee. This is on a 9,000-acre deep well lease on Wentworth's 27,557-acre mineral block in East Texas. The Lessee's current lease on the property expires November 1, 2009.

The extension will give the Lessee until April 2010 to drill additional deep Bossier/Haynesville wells on the western portion of the lease. In return for the six-month extension, the Lessee assigned 100 percent of their working interest (with a 75 percent NRI) in the Lessee's shallow leases on the mineral block to Wentworth Energy, Inc. Wentworth Energy has identified three additional shallow well locations with a potential JV Partner out of Tyler, Texas. They are continuing to develop additional drill sites. They will announce these once final agreements are signed.

Wentworth Energy, Inc. (WNWG.OB) closed at $0.0065 up 8.33 percent. Volume was 4,500.

Kodiak Energy Inc. (KDKN)

SmallCapInvestor.com, SmallCap Voice, Raging Stocks, Investor Spec Sheet, Street Insider, Daily Profit, StreetAuthority Financial, The Green Baron, Emerging Markets, Global Equity Report, and 24-7 Stock Alert reported earlier on Kodiak Energy Inc. (KDKN). In addition, Penny Stock Explosion, Dubai Penny Stocks, Schaeffer's, The Upturn Stock, Daily Profit, HotOTC.com, Monster Stock Alerts, Cool Penny Stocks, Penny Invest, and Penny Stock Finder reported on the Company, and today we do as well, here at the QualityStocks Daily Newsletter.

Headquartered in Calgary, Alberta, Kodiak Energy Inc. is an oil and gas exploration and development company. Trading on the TSX Venture Exchange (KDK) and the OTCBB (KDKN), they focus on creating a portfolio of North American assets that offer production opportunities and asset growth through exploration. Kodiak is a multi-project enterprise with a land position of over 340,000 gross acres leased for exploration and development.

The Company's mission is the development of onshore oil, gas, and CO2 properties in the North American arena. Kodiak Energy has lease holdings in Montana, Alberta, and British Columbia. They also have prospects in the central Mackenzie River Valley of the Northwest Territories, Canada and in northeastern New Mexico. Through their private subsidiary, Cougar Energy, Inc., they are developing the projects of Lucy in the Horn River Basin in northeast British Columbia. The basin has a reputation within the oil and gas industry for its large scale, excellent prospects, and reserves of shale gas. Through Cougar Energy, Inc., they are also developing the CREEnergy Joint Venture located in north central Alberta.
Their prospects also include the "Little Chicago" or "EL 413" prospect in the Northwest Territories, and the Sofia project in northeastern New Mexico. Their "Little Chicago" or "EL 413" prospect is located in the central Mackenzie River Valley of the Northwest Territories.  It has multi-formation targets for light and medium oil as well as natural gas prospects. Kodiak's Northeast New Mexico prospect is mainly a CO2 prospect for the growing industry demand for enhanced oil recovery in the area.

Kodiak Energy, Inc. reported this year that their majority controlled private subsidiary, Cougar Energy, Inc., funded, and completed the requirements of the "exclusivity contract" of the CREEnergy Oil and Gas Inc. agreement announced on December 1, 2008. The agreement provides for an "exclusivity contract" with CREEnergy for oil and gas properties for up to 15 townships or 345,000 gross acres of mineral rights in north central Alberta, Canada. The initial leases are for mineral rights on 46,000 gross acres for a lease term of 10 years.

Kodiak Energy, Inc. announced this past July that Cougar Energy, Inc. reached an agreement in principle with a private company to acquire the wells, facilities, and production with operations in and adjacent to the CREEnergy project. The acquisition will add 11 producing wells and additional 21 low cost workover or recompletion candidates, essential water disposal and production facilities, and associated pipelines. Subsequently Kodiak announced in August that Cougar Energy, Inc. made another acquisition for wells, facilities, and production from a private company with operations in and adjacent to the CREEnergy project. The acquisition adds two more producing wells, and four suspended wells, as well as associated production facilities. The existing wells and reserves are located in the Kidney and Equisetum fields.

Kodiak Energy Inc. (KDKN) closed today at $0.49 up 15.29 percent. Volume was 2,378,399 for a 3-month average of 95,348.

The QualityStocks Company Corner

Clenergen Corp. (CRGE)
eDOORWAYS Corporation (EDWY)
Muscle Flex Inc. (MFLI)
Kraig Biocraft Laboratories (KBLB)

General Environmental Mgnt, (GEVI)
eDoorways Corp. (EDWY)
Axial Vector Energy Corp. (AXVC)
Jiangbo Pharmaceuticals Inc. (JGBO)

Clenergen Corp. (CRGE)

The QualityStocks Daily Newsletter would like to spotlight Clenergen Corp. (CRGE). Today, Clenergen Corporation closed trading at $1.23, which was down 3.91 percent. Their volume today was 46,613 shares. Their 3-month average volume is 1,760 shares.

Clenergen Corporation announced today that it has secured long term leases effective 25 years on plantation land parcels in the Tirunelveli District of Tamilnadu for cultivation of its feedstock. The company has already begun working on the first parcel of 850 acres for a detailed survey prior to designing the irrigation system and commercial planting.

Clenergen Corporation (CRGE) is focused on using a proprietary biomass process to generate renewable electricity. The company has identified two fast growing species of tree and applied a proprietary Tree Adaption Process for rapidly increasing the growth rate 30-40%. This substantial growth rate will enable the production of an economically viable source of feedstock/biomass for creating a renewable source of electricity.

The company anticipates the implementation of a 71MW per hour biomass power plant in Tamilnadu, India, which will be phased over a 42 month period. It is expected that by 2010, the power plant will generate 15MW per hour. Utilizing 6,500 acres of land for the cultivation of feedstock, the project is scalable and capable of expanding to 121MW per hour within a 5 year period.

Because the company will be using renewable biomass, organic material derived from plant matter not related to food production, it is able to produce clean, sustainable energy without endangering the food supply. Additionally, unlike fossil fuels that only add CO2 to the atmosphere, biomass generates positive carbon emissions credits through the process of photosynthesis.

Clenergen Corporation (CRGE) is backed by an experienced management team with a track record of success and operational expertise. The company has also established third party partnerships to enable the business to achieve its business goals and enable it to meet or exceed its financial forecasts and projections. To date, Clenergen has begun operations in the following markets: Guyana, Ghana, Uganda, Brazil Russia and South Africa. Disclaimer

Clenergen Corp. Blog

Clenergen Corp. News:

Clenergen Corporation (OTCBB: CRGE) Appoints Dale Shepherd Chief Financial Officer and Abillish Kamti as Chief Financial Officer of Clenergen India Private Limited

Clenergen Corporation (OTCBB:CRGE) Launches Biomass Research Project With Leading Indian University

Clenergen Corporation (OTCBB:CRGE) Appoints Dale Shepherd Chief Financial Officer and Abillish Kamti as Chief Financial Officer of Clenergen India Private Limited

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today, eDOORWAYS Corp. closed trading at $0.1340, which was down 7.59 percent. Their volume today was 16,280,998 shares, substantially greater than the daily average.

eDOORWAYS Corp. is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

Muscle Flex Inc. (MFLI)

The QualityStocks Daily Newsletter would like to spotlight Muscle Flex Inc. (MFLI). The QualityStocks Daily Newsletter would like to spotlight Muscle Flex Inc. (MFLI.PK). Today, Muscle Flex Inc. closed trading at $0.02, which was down 16.67 percent. Their volume today was 4,091,400 shares.

Muscle Flex Inc. announced today that they will be releasing The BUDDY Tablet Caddy™ and the Beagle StepFit™ Pedometer simultaneously in early November to coincide with a number of significant national promotions Muscle Flex has scheduled.

Muscle Flex Inc. (MFLI) announced today that Founder & CEO, Danny Alex, talked with online radio host Stuart Smith of SmallCapVoice.com and provided a detailed, one on one question and answer session about Muscle Flex Inc.

Muscle Flex Inc. (MFLI) announced details of its second product release, The Beagle StepFit™ Pedometer (www.BeagleStepFit.com). Clipping onto the waist of an individual for walking or running, the device provides the wearer with detailed information and innovative features.

Muscle Flex Inc. announced that Muscle Flex CEO, Danny Alex, will attend this year's Emmy Awards show Sunday, September 20 in Los Angeles. The company also announced that its Muscle Flex VATA Brasil Sports & Active Wear Line will be included in the "Andre Agassi's 14th Annual Grand Slam for Children" Gift Basket by Lash Fary and Distinctive Assets.

Muscle Flex Inc. (MFLI) is a leading edge fitness, health and lifestyle company focused on developing exciting brands and new products to market using direct response TV advertising and infomercials as well as cutting edge brand and image marketing. The company has designed all its products with the average person's lifestyle in mind.

Muscle Flex Inc. VATA Brasil sports and active wear collection is an ultra comfortable active wear line that utilizes superior moisture control fabric. The VATA Brasil OneFit fabric is an amazing innovation in sporting wear apparel, offering the advantages of being lightweight, highly elastic, and having four times the filaments than regular fabric.

The company’s newest product, The BUDDY Tablet Caddy™, is a personal, compact and portable tablet caddy with three individual compartments and a digital timer to remind users when it’s time to take vitamins or prescriptions. The pharmacist approved tablet caddy ensures the maximum effectiveness of all medications and supplements.

Founder and CEO Danny Alex leads the company with nearly three decades of experience in the health, fitness and athletic lifestyle. Since a young age, regular exercising and maintaining a healthy lifestyle has been a key part of Danny’s life. Today, it is his passion to help others get excited about themselves through fitness and healthy living. Disclaimer

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB) Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.0180, which was up 12.50 percent from yesterday's close. Their volume today was 1,527,631 shares for a 3-month average volume of 928,514 shares.

Kraig Biocraft Laboratories, Inc. (KBLB) a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. (KBLB) is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Blog

News for Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories, Inc. Greatly Exceeds Its Performance Goals

SectorWatch.biz: Paving the Way for Spider Silk

The following is an investment opinion release issued by EmergingStockReport.com

General Environmental Management, Inc. (GEVI.OB) Offers Clients Waste Minimization Strategies

General Environmental Management Inc. is an environmental and waste management services firm which provides a suite of services for their clients including: field services, remediation, transportation, EHS compliance services, on-site technical services and off-site treatment for both hazardous and non-hazardous materials.

General Environmental assists its clients, which include both public and private institutions, in meeting regulatory requirements for the disposal of wastes. An ongoing, primary focus of the company is to find a reuse or recycle option for clients to reduce the burden of the disposal of waste in our environment.

Another primary focus of the company is waste minimization. What exactly is waste minimization? Waste minimization is any activity that reduces the amount of hazardous material that permanently leaves the production process as waste.

General Environmental considers waste minimization and waste reuse to be the peak of the waste management service pyramid. The company believes reducing waste should be the first consideration in any waste management strategy.

The reasons for institutions to develop a waste minimization plan include:

• Lower costs and greater efficiencies.
• Reduced government scrutiny and intrusion through a reduction in self-reporting obligations.
• Improved community relations through a more positive public image.
• Enhanced employee morale by creating a more inviting and safe work environment.

Waste minimization may include in-plant recycling and improvement of plant operating procedures along with source reduction. Source reduction includes both actions that reduce the net amount of hazardous waste generated and action taken before waste is generated that lessen its hazardous properties. Common source reduction strategies include: materials substitution, product substitution and reformulation, and process or equipment change.


eDoorways Corp. (EDWY.PK) Helps Businesses ‘Mine’ for Gold Nugget Prospects

For small businesses in America, a huge gap exists between consumer practice and retail response. While nearly 75% of US consumers use the Internet while shopping for goods and services, only 44% of small businesses have a Web presence. In the online marketplace, small businesses tend to lag far behind the large e-retailers and local competition.

Gary K. Kimmons – founder, chairman, president and CEO of eDoorways – spoke to the reasons why small businesses lag behind in their online presence, “Small businesses often lag behind the competition due to lack of computer know-how and inability to adapt their messaging, resulting in a failure to make vital connections in the online marketplace.”

But now there is a solution for small business owners. eDoorways, a revolutionary new business-to-consumer social network website that makes instant connections between small businesses and pre-qualified, gold nugget sales prospects. The company’s next generation networking interface is unique in that it delivers a real-time collaborative problem-solving venue with capabilities for instantaneously sourcing correct information, products, services and solutions.

In addition, vendors can ‘rent’ or ’sublease’ certain “PowerKeys” (e.g. “bottled water”, “private tutor”, etc.) to generate more prospects and business. This feature, in effect, creates an ‘economy’ within the platform beyond the selling of advertising or individual buy-sell events.

eDoorways will open its initial SOLVE doorway, covering the Austin, Texas market, on October 1, 2009. A market-by-market national rollout is expected to follow. Mr. Kimmons of eDoorways said, “We envision eDoorways as a machine that formalizes how businesses reach prospective buyers in the most efficient way possible. We’re interested in using the Internet as a grassroots economic development tool that will rally and empower America’s small businesses, drive commerce, and encourage job creation.”

Axial Vector Energy Corp. (AXVC.PK) Management & Advisory Team

Axial Vector Energy Corp., a leader in energy conversion efficiency, is fortunate in that it is run by one of the most seasoned international management and advisory teams, with over a century of combined experience. This is critical in starting and growing a company, obtaining the required capital, locking in the rights to key products and technologies, and ensuring that your message gets out to the public on a worldwide basis.

• Samuel Higgins, Axial Chairman, has been involved in raising and investing capital globally for over 30 years, with extensive experience in the energy industry, as well as in real estate and technology. His global contacts include his role as Managing Director of a family office in Latin America that advises high net worth individuals. He also has strong connections in the Middle East, and is partner in Emirates International Capital Advisory based in Dubai, where he now lives with his family. He is also known for his lectures on technology development and first-mover breakthrough events affecting GCC (Gulf Cooperation Council) countries
• Sanjai Chhaunker, Axial President & CEO, is a finance and management professional with expertise in international business, and over 15 years of experience in financial management and business planning. He has provided advisory services to clients in financial and technical collaborations, including technology transfers and marketing. This has helped him develop a strong business network in countries throughout the world, including the U.S., India, UAE, Mexico, Brazil, Canada, Hong Kong, Malaysia, and others.

• Miguel Gonzales, Axial Legal Advisor, is an independent legal consultant and practicing attorney, with over 28 years of legal consulting experience. During this time he was Vice President of Cortez Carbajal y Asociados Law Firm, and is the founder of the law firm Jazo – Gonzalez y Asociados, in charge of the Legal and Corporate Department, and consultant in foreign investment.

• Benjamin Langford, Axial Secretary/Treasurer and Director, is president and CEO of Langford Unlimited, and was earlier the president of Langford Enterprises, involved in technology investments. He started his environment awareness career with Jefferson Smurfit Corporation, a leader in global resources and recycling.


Jiangbo Pharmaceuticals Inc. (JGBO.OB) Posts Strong Q4 and FY09 Results, High Expectancies for 2010

Jiangbo Pharmaceuticals Inc. today announced its fiscal and fourth-quarter results for the period ended June 30, 2009. The China-based pharmaceutical company posted solid results for both periods and gave a summary of achievements for the year, as well as its outlook for 2010.
“We are delighted to report a strong finish to fiscal 2009, with revenues and operating income significantly exceeding our prior guidance for the year. We believe that the factors that contributed to this performance were strong sales from our new products and the successful restructuring of our sales and marketing network. With nearly $63 million in operating cash flow in fiscal year 2009, we ended the fiscal year with over $100 million in cash. We believe that our strong cash position will provide us with significant flexibility to pursue continued organic growth and strategic acquisitions,” Wubo Cao, chairman and CEO of Jiangbo stated in the press release.

Revenues grew 10.1 percent to $31.2 million, up from $28.3 million reported the same quarter the year prior. Net income increased 19.9 percent to $11.5, as compared to $9.6 million for the same quarter last year.

For fiscal year 2009 the company posted a 17.9 percent increase to $117.4 million, as compared to $99.5 million for fiscal 2008. Net income grew 28.6 percent to $28.9 million, as compared to $22.5 million for fiscal 2008.

In July 2008, Jiangbo received approval from China’s State Food and Drug Administration (SFDA) for the production and distribution of Radix Isatidis Dispersable Tablets, an herbal-based traditional Chinese medicine for the treatment of viral influenza.

In January 2009, the company acquired Shandong Hongrui Pharmaceutical Company, including all assets and legal rights to distribute Hongrui’s 22 traditional Chinese medicines. The same month, Jiangbo revamped its sales network to accommodate distribution through 28 large regional distributors.

The company anticipates fiscal 2010 to far surpass fiscal 2008 and 2009, expecting revenues for the year between $96 million and $98 million based on the introduction of new drugs and higher volume of various product sales.

“Fiscal 2010 is expected to be a transitional year for Jiangbo as we upgrade our TCM production facility, prepare for the introduction of new drugs, and pursue additional opportunities for both organic growth and potential strategic acquisitions. Our current outlook reflects only the drugs that we have in hand today and will be subject to update as we execute strategic initiatives to expand our market position and profitability in the future. We remain very confident regarding our future growth prospects and look forward to sharing further details with our shareholders as our expansion plans reach a definitive stage,” Cao stated.



Sponsors of the Day

The QualityStocks Public Company Sponsor News

Advanced Visual Systems Inc. (AVSC) Data Visualization Software from Advanced Visual Systems Adds Powerful Functionality to Business Intelligence Dashboards



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336